# Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

> **NCT00070616** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 25 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Myeloma

## Interventions

- **DRUG:** Palifermin 6 x 60 μg/kg/day
- **DRUG:** Palifermin 2 x 180 μg/kg/day
- **RADIATION:** radiotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT00070616
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070616, "Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00070616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*